Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (121-130 of 272) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin levelValérie Boige, Julien Taïeb, Mohamed Hebbar, et al.
Plos One|August 8, 2015
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic HepatitisMarika Rudler, Sarah Mouri, Frederic Charlotte, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 9, 2019
Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastographyViola Knop, Sophie-Charlott Neuberger, Sabine Marienfeld, et al.
Clinics and Research in Hepatology and Gastroenterology|May 11, 2012
Optimal nonsurgical management of peptic ulcer bleeding, including arterial embolization is associated with a mortality below 1%Marika Rudler, Philippe Cluzel, Julien Massard, et al.
Clinical Chemistry|July 20, 2007
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stagesThierry Poynard, Philippe Halfon, Laurent Castera, et al.
Gastroenterologie Clinique Et Biologique|August 16, 2002
[What are the indications for treatment of acute hepatitis C?]Robert P Myers, Corinne Regimbeau, Joseph Moussalli, et al.
The Journal of Rheumatology|November 2, 2004
Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virusDamien Sene, Pascale Ghillani-Dalbin, Vincent Thibault, et al.
Journal of Hepatology|May 23, 2012
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large populationThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
Hepatology (Baltimore, Md.)|November 1, 2007
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failureDominique Thabut, Julien Massard, Alice Gangloff, et al.
Cancer|March 3, 2007
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II studySamy Louafi, Valérie Boige, Michel Ducreux, et al.
Pageof 28

Showing results (121-130 of 272) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin levelValérie Boige, Julien Taïeb, Mohamed Hebbar, et al.
Plos One|August 8, 2015
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic HepatitisMarika Rudler, Sarah Mouri, Frederic Charlotte, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 9, 2019
Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastographyViola Knop, Sophie-Charlott Neuberger, Sabine Marienfeld, et al.
Clinics and Research in Hepatology and Gastroenterology|May 11, 2012
Optimal nonsurgical management of peptic ulcer bleeding, including arterial embolization is associated with a mortality below 1%Marika Rudler, Philippe Cluzel, Julien Massard, et al.
Clinical Chemistry|July 20, 2007
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stagesThierry Poynard, Philippe Halfon, Laurent Castera, et al.
Gastroenterologie Clinique Et Biologique|August 16, 2002
[What are the indications for treatment of acute hepatitis C?]Robert P Myers, Corinne Regimbeau, Joseph Moussalli, et al.
The Journal of Rheumatology|November 2, 2004
Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virusDamien Sene, Pascale Ghillani-Dalbin, Vincent Thibault, et al.
Journal of Hepatology|May 23, 2012
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large populationThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
Hepatology (Baltimore, Md.)|November 1, 2007
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failureDominique Thabut, Julien Massard, Alice Gangloff, et al.
Cancer|March 3, 2007
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II studySamy Louafi, Valérie Boige, Michel Ducreux, et al.
Pageof 28